The benefits offered to patients by attempting the rechanneling of a chronic total occlusion are still unclear. Additionally, sometimes the procedural risks are somewhat undetermined. Taking into account these controversies, this work sought to prove whether successful rechanneling of a chronic total occlusion improves ventricular function. This is not a soft endpoint; it has been<a href="https://solaci.org/en/2018/11/23/clinical-improvement-without-ventricular-function-improvement-after-cto/" title="Read more" >...</a>
Safety of Combining New Anticoagulant Agents and Dual Antiplatelet Therapy
Atrial fibrillation is the most common arrhythmia and its combination with a history of acute myocardial infarction or coronary angioplasty is quite frequent. According to this study (recently published in JACC), in a real-world population, the combination of direct anticoagulant agents and dual antiplatelet therapy reduces significantly the risk of bleeding and provides similar thromboembolic<a href="https://solaci.org/en/2018/11/20/safety-of-combining-new-anticoagulant-agents-and-dual-antiplatelet-therapy/" title="Read more" >...</a>
Complete Revascularization Improves Long-Term Prognosis in Acute Coronary Syndromes
Going beyond the culprit artery during angioplasty was associated with lower mortality, although this was a cohort study that should be confirmed through randomized trials. According to this new observational study, patients experiencing non-ST-segment elevation myocardial infarction with multivessel disease seem to benefit from complete revascularization during initial angioplasty. This study, published online before<a href="https://solaci.org/en/2018/11/01/complete-revascularization-improves-long-term-prognosis-in-acute-coronary-syndromes/" title="Read more" >...</a>
Predictors of Conduction Disturbances Requiring a Late Permanent Pacemaker
This analysis shows that baseline right bundle branch block and increased PR length after transcatheter aortic valve replacement (TAVR) are independent predictors of advanced conduction disturbances requiring late pacemaker implantation. A simple electrocardiography can detect these potentially fatal conduction disturbances that might happen more than 48 hours after TAVR. Data from consecutive TAVR patients from<a href="https://solaci.org/en/2018/10/18/predictors-of-conduction-disturbances-requiring-a-late-permanent-pacemaker/" title="Read more" >...</a>
Safety of Early Carotid Artery Stenting in Symptomatic Patients
This work shows the safety of carotid artery stenting within 14 days of a stroke and, so far, this is the largest series of symptomatic patients published by an institution. The exact moment to conduct this procedure after an acute stroke is still controversial, although most publications so far have favored early endarterectomy over early angioplasty.<a href="https://solaci.org/en/2018/10/12/safety-of-early-carotid-artery-stenting-in-symptomatic-patients/" title="Read more" >...</a>
TCT 2018 | OAC-ALONE: Anticoagulation Alone 1 Year After Stenting in Patients with Atrial Fibrillation
Up to now, there had been no randomized controlled trial assessing oral anticoagulation alone vs. oral anticoagulation plus antiplatelet therapy in patients with atrial fibrillation 1 year after stenting in a setting of stable coronary disease. Such was the vacuum that this work, presented at TCT 2018 and published simultaneously in Circulation, attempted to fill. This trial<a href="https://solaci.org/en/2018/10/08/tct-2018-oac-alone-anticoagulation-alone-1-year-after-stenting-in-patients-with-atrial-fibrillation/" title="Read more" >...</a>
Simple Lab Tests to Better Stratify Low Flow and Low Gradient AS Patients
Combining B-type natriuretic peptide (BNP) and high-sensitive cardiac troponin T measures undeniably helps to better stratify severe aortic stenosis patients with low flow and low gradient. Many patients in these conditions clearly benefit from a transcatheter aortic valve replacement (TAVR) procedure, and for others it is simply useless, and given its high cost, better stratification<a href="https://solaci.org/en/2018/09/17/simple-lab-tests-to-better-stratify-low-flow-and-low-gradient-as-patients/" title="Read more" >...</a>
An Effort Worth Your While: Rechanneling vs. Optimal Medical Treatment in Total Occlusions
Successful rechanneling of a chronic total occlusion (currently around 90%) leads to significant improvement in quality of life and symptom frequency in patients with stable chronic angina compared with optimal medical treatment alone. These results are promising and what we ultimately expected, although symptoms, as a primary endpoint in themselves, are in the eye of<a href="https://solaci.org/en/2018/09/14/an-effort-worth-your-while-rechanneling-vs-optimal-medical-treatment-in-total-occlusions/" title="Read more" >...</a>
See the presentations of the 9th José Gabay Fellow Course
We are deeply thankful to all interventional physicians who, motivated by their great scientific and educational vocation, presented their works at the “José Gabay” Course. Read the presentations below: Module I: Fundamentals and Basic Elements. Leiva Pons, José Luis. “Vascular Closure Devices. Step by Step.” (Spanish version) García García, Hector. “Current Status of Coronary Intervention:<a href="https://solaci.org/en/2018/09/14/see-the-presentations-of-the-9th-jose-gabay-fellow-course/" title="Read more" >...</a>
Stroke Rate after CABG vs PCI in over 10,000 Patients
Repeat revascularization rate has historically been the weak spot of PCI when compared against CABG: we are still unable to compete with a well done internal mammary artery graft connected to the anterior descending artery. However, repeat revascularization is the soft of end points commonly assessed in trials, and even though several studies have shown<a href="https://solaci.org/en/2018/09/12/stroke-rate-after-cabg-vs-pci-in-over-10000-patients/" title="Read more" >...</a>